AS 602801 - CAS# 848344-36-5 Catalog No.:M10675-10 dBET1 induces a potent and

dBET1 induces a potent and superior inhibitory effect on MV4

Bimatoprost enhances the pressure-sensitive outflow pathway

1 nm in 18 human tumor cell lines) and had substantially less interaction with multidrug resistance protein (P-glycoprotein) than currently used antimicrotubule agents

8 days) treatment reduces concentration dependently cell survival in both cell lines to a similar extent

(+)-Apogossypol is expected to exhibit lower toxicity while maintaining the significant anti-growth and anti-tumor activities in vitro

AS 602801 - CAS# 848344-36-5 Catalog No.:M10675-10 dBET1 induces a potent andBentamapimod, also known as AS602801 and PGL5001, is a JNK Inhibitor. AS602801 induces regression of endometriotic lesions in animal models. AS602801 interrupts immune pathways. Bentamapimod induced regression of endometriotic lesions in endometriosis rodent animal models without suppressing ER action. Endometriosis is an estrogen (ER) dependent gynecological disease caused by the growth of endometrial tissue at extrauterine sites. Product information